Mika Derynck's most recent trade in Enliven Therapeutics Inc was a trade of 20,491 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enliven Therapeutics Inc | Mika Derynck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 20,491 | 20,491 | - | - | Stock Option (right to buy) | |
| Enliven Therapeutics Inc | Mika Derynck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 23,364 | 23,364 | - | - | Stock Option (right to buy) | |
| Enliven Therapeutics Inc | Mika Derynck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 87,373 | 87,373 | - | - | Employee Stock Option (right to buy) | |
| Enliven Therapeutics Inc | Mika Derynck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 27,567 | 27,567 | - | - | Stock Option (right to buy) |